Using melatonin to prevent delirium in hospitalized older patients
Official title: Effect of Melatonin Versus Placebo for Prevention of Delirium Among Medically Hospitalized Patients: Study Protocol for a Single-Center, Double-Blinded, Randomised Controlled Trial
Run by Sultan Qaboos University · NCT06509191 · Data updated 2026-11-12
This study is testing if melatonin can help prevent delirium in older patients aged 65 and up who are in the hospital.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | Sultan Qaboos University Academic / other |
| Locations | 2 sites (Muscat and 1 other locations) |
| Status | Recruiting |
| Started | September 30, 2024 |
| Main results expected | March 2025 |
| Study ends | June 2025 |
| Registry record updated | January 14, 2025 |
| Trial ID | NCT06509191 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients aged 65 years and older who are acutely admitted to the General Internal Medicine Unit.
✕Probably not a fit
Patients who are already experiencing delirium at the time of randomization or those with specific contraindications will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the efficacy of melatonin, a neurohormone that regulates the sleep-wake cycle, in preventing delirium among medically hospitalized patients aged 65 and older. It employs a randomized, double-blind, placebo-controlled design to ensure robust results. Given the high prevalence of delirium in this demographic and its association with adverse health outcomes, the study aims to provide valuable insights into effective prevention strategies. The trial addresses limitations of previous studies by utilizing a larger sample size and a more rigorous methodology.
Why it matters
Potential benefit: If successful, this study could significantly reduce the incidence of delirium in hospitalized older adults, improving their overall health outcomes.
How similar studies have gone: While previous trials have explored melatonin's role in delirium prevention, this study aims to address their limitations, making it a novel approach in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient aged 65 years and above acutely admitted under the care of General Internal Medicine Unit Exclusion Criteria: * Patients admitted to the ward, however meeting requirement for vasopressors or non-invasive ventilation. * Patient admitted through emergency to Intensive Care Unit (ICU) or High Dependency Unit (HDU). * Aphasic patients. * Patients with language barriers. * Already taking melatonin or ramelteon at the time of randomization. * Presence of delirium at the time of randomization. * If enteral medications are contraindicated due to gastrointestinal conditions. * If enteral medications are not allowed due to unavailability of nasogastric tube * Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) (liver function tests) \> 3 times the upper limit of normal. * Patient on strong cytochrome P450 1A2 (CYP1A2) inhibitors (namely: fluvoxamine and viloxazine) . * Patient with active alcohol drinking or admitted with alcohol withdrawal syndrome. * Subject or proxy unable to provide informed consent within 24 hours of admission. * Patients with the following autoimmune diseases (Rheumatoid arthritis, inflammatory bowel disease and systemic lupus erythematosus). * Allergy to melatonin.
Where it's running
-
Sultan Qaboos University Hospital
Muscat, Oman Recruiting -
Sultan Qaboos University Hospital
Muscat, Oman Not yet recruiting
Study contacts
- Study coordinator: Abdullah M Al Alawi, FRACP
- Email: dr.abdullahalalawi@gmail.com
- Phone: +96895384990
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can citicoline help prevent cognitive decline after delirium in older adults with hip fracture?
This study tests whether taking citicoline for 6 months after discharge helps prevent cognitive decline in adults 65 and older who had delirium during hospitalization for hip fracture.
-
Delirium and Light: Exploring Modifiable Risk Factors in Critically Ill Adults
This pilot observational study tests whether circadian-light factors influence delirium risk in adults recovering in critical care.
-
VR-based cognitive games to help prevent delirium after big surgery
A VR-based cognitive stimulation game is being tested to see if it can help prevent delirium in adults 65 and older after major surgery.
-
Computer-assisted cognitive stimulation for delirium in older adults
This will try adding tablet-based cognitive exercises to sleep and mobility support to see if they reduce delirium in people aged 60 and older in subacute care.
-
Letting patients drink clear fluids until called to the operating room to shorten pre-surgery fasting
This project will try letting elective procedure patients drink clear liquids until they're called to the operating room to see if fasting times, comfort, and perioperative outcomes improve.
-
Lemborexant to help Sleep and Delirium in older ICU patients
This study tests whether lemborexant, a sleep medication, helps improve sleep and reduce delirium in adults 65 and older in the ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.